Erythema Multiforme Minor Can Recur Within the Same Week
Yes, erythema multiforme (EM) minor can recur within the same week, though this represents an unusually rapid recurrence pattern. The typical recurrence pattern shows episodes occurring at intervals of several months rather than days, but the disease's variable nature means shorter intervals are possible.
Understanding Recurrence Patterns in EM
The natural history of recurrent EM shows considerable variability in timing:
- Typical recurrence intervals: The average interval between episodes is approximately 4.9 months 1, with patients experiencing a mean of 6 attacks per year (range 2-24) 2
- Episode duration: Individual episodes typically last about 3 weeks 1, meaning a new episode starting within the same week would represent either an unusually short interval between distinct episodes or continuation of the same episode with waxing/waning severity
- Chronicity: The disease demonstrates significant chronicity, with a mean duration of 9.5 years (range 2-36 years) 2
Recurrence is More Common in Certain Populations
Pediatric patients show higher recurrence rates (up to 18% in children) 3, particularly because infections (which can recur) are the predominant trigger rather than drugs (which can be avoided). Among recurrent cases, 61% are triggered by herpes simplex virus (HSV) 4.
Clinical Implications for Same-Week Recurrence
If you're seeing what appears to be EM recurring within the same week, consider:
- Is this truly a new episode or the same episode? Individual EM lesions are typically fixed for a minimum of 7 days 5, so lesions appearing within days may represent progression of the initial episode rather than true recurrence
- HSV reactivation: All patients with recurrent EM in one study had histories of HSV infections preceding at least one episode 1, and compelling evidence links HSV to recurrent disease
- Isomorphic phenomenon: This occurs in 86% of recurrent EM patients (19 of 22) 1, where new lesions appear at sites of skin trauma, which could be mistaken for rapid recurrence
Management Considerations
For patients with frequent recurrences:
- First-line prophylaxis: Continuous oral acyclovir or patient-initiated 5-day courses at HSV onset show benefit in 55% of patients 2
- Second-line options: Dapsone for acyclovir non-responders, with azathioprine achieving complete disease suppression in the most resistant cases 2
- Symptomatic treatment: Topical steroids or antihistamines for acute episodes 5
Critical Distinction from Stevens-Johnson Syndrome
The guidelines emphasize that EM does not progress to SJS/TEN 3. Patients with EM are typically constitutionally well and make good recovery with rare long-term sequelae (1.3%) 4, unlike SJS/TEN which causes severe systemic illness.